Skip to content
Open access · CC-BY via OpenAlex

No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients

Biyan Nathanael Harapan, Clara Frydrychowicz, Joseph Claßen, Christian Wittekind, Tanja Gradistanac, Jost‐Julian Rumpf, Wolf C. Mueller

Parkinsonism & Related Disorders · 2020 · ▲ 23 citations

Abstract

BACKGROUND: Neuronal alpha-synuclein (α-Syn) aggregation in the brain is believed to be a central component of the pathogenesis of Parkinson's disease (PD). α-Syn aggregates in the gastrointestinal tract have been suggested as a potential biomarker of PD that may even signal an early event of the Parkinsonian molecular pathology. However, studies further investigating this hypothesis have produced mixed results. OBJECTIVE: To determine whether the prevalence of α-Syn- and serine 129-phosphorylated α-Syn (Ser129p-α-Syn) depositions detected in intestine from PD patients differed from that of non-Parkinsonian controls. METHODS: In this retrospective study, we examined post-mortem small and large intestine samples of 25 PD patients and 20 age- and sex-matched controls without PD. Specimens were taken from archived paraffin-embedded tissue blocks. Immunohistochemical techniques were applied to detect α-Syn and Ser129p-α-Syn aggregates in situ. Immunoreactivity was quantified by a new approach that employed the detailed assessment of α-Syn- and Ser129p-α-Syn-positive morphological structures of the enteric nervous system (i.e., nerve fibers, myenteric and submucous plexus as well as ganglion cells). RESULTS: α-Syn immunoreactivity was a common finding in intestinal tissues from PD patients and controls. Importantly, α-Syn and Ser129p-α-Syn immunoreactivity were significantly reduced in PD patients compared to controls in each of the morphological structures examined. CONCLUSIONS: Immunohistochemical detection of intestinal α-Syn and Ser129p-α-Syn seems to be a frequent and potentially normal finding. Neither α-Syn nor Ser129p-α-Syn immunoreactivity may, therefore, be regarded as a molecular intestinal biomarker of PD pathology. Reduced intestinal α-Syn and Ser129p-α-Syn immunoreactivity in PD patients rather reflect PD-related neuronal degeneration.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.parkreldis.2020.08.020
Canonical
link ↗
Fetched
2026-10-21 MST

Cite this

APA
Harapan, B.N., Frydrychowicz, C., Claßen, J., Wittekind, C., Gradistanac, T., Rumpf, J., &amp; Mueller, W.C. (2020). No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients. <em>Parkinsonism & Related Disorders</em>. https://doi.org/10.1016/j.parkreldis.2020.08.020
Vancouver
Harapan BN, Frydrychowicz C, Claßen J, Wittekind C, Gradistanac T, Rumpf J, et al. No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients. Parkinsonism & Related Disorders. 2020. doi:10.1016/j.parkreldis.2020.08.020.
BibTeX
@article{biyan2020Noenha, title = {No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients}, author = {Biyan Nathanael Harapan and Clara Frydrychowicz and Joseph Claßen and Christian Wittekind and Tanja Gradistanac and Jost‐Julian Rumpf and Wolf C. Mueller}, journal = {Parkinsonism & Related Disorders}, year = {2020}, doi = {10.1016/j.parkreldis.2020.08.020}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings